Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study-Reference-Cited by-同舟云学术

Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study

Published:2013-01-24 Issue:2 Volume:88 Page:130-134
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol

Author:

Merkel Drorit¹,Filanovsky Kalman²,Gafter-Gvili Anat³,Vidal Liat³,Aviv Ariel⁴,Gatt Moshe E.⁵,Silbershatz Itay⁶,Herishanu Yair⁷,Arad Ariela⁸,Tadmor Tamar,Dally Najib⁹,Nemets Anatoly¹⁰,Rouvio Ory¹¹,Ronson Aharon¹²,Herzog-Tzarfati Katrin¹³,Akria Luiza¹⁴,Braester Andrei¹⁴,Hellmann Ilana¹⁵,Yeganeh Shay¹⁶,Nagler Arnon¹,Leiba Ronit¹⁷,Mittelman Moshe¹⁸,Ofran Yishai

Affiliation:

1. Division of Hematology; Sheba Medical Center, Tel-Hashomer, Tel Aviv University; Israel

2. Department of Hematology; Kaplan Medical Center; Rehovot; Israel

3. Institute of Hematology; Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah-Tiqva, Tel Aviv University; Israel

4. Department of Hematology; Emek Medical Center; Afula; Israel

5. Department of Hematology; Hadassah Hebrew University Medical Center; Jerusalem; Israel

6. Hematology Institute; Wolfson Medical Center; Holon; Israel

7. Hematology Institute; Sourasky Medical Center; Tel Aviv; Israel

8. Department of Hematology; Sanz Medical Center, Laniado Hospital; Netanya; Israel

9. Department of Hematology; Ziv Medical Center; Zefat; Israel

10. Department of Hematology; Barzilai Medical Center; Ashkelon; Israel

11. Institution of Hematology; Soroka University Medical Center; Beer-Sheba; Israel

12. Department of Hematology; Shaare Zedek Medical Center; Jerusalem; Israel

13. Hematology Unit; Assaf Harofe Medical Center; Israel

14. Department of Hematology; Western Galilee Hospital; Nahariya; Israel

15. Hematology Unit; Meir Medical Center; Kfar Saba; Israel

16. Hematology Unit; Poria Medical Center; Hedera; Israel

17. Quality of Care Unit; Rambam Health Care Campus; Haifa; Israel

18. Department of Medicine; Sourasky Medical Center, Tel Aviv University; Israel

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23368/fullpdf

Reference26 articles.

1. Infections in myelodysplastic syndromes;Toma;Haematologica,2012

2. Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: Azacitidine compared with low dose ara-C;Fenaux;Br J Haematol,2010

3. 5-Azacitidine efficacy and safety in patients aged >65 years with myelodysplastic syndromes outside clinical trials;Breccia;Leuk Lymphoma,2012

4. Effects of azacitidine compared with conventional care regimens in elderly (>/= 75 years) patients with higher-risk myelodysplastic syndromes;Seymour;Crit Rev Oncol Hematol,2010

5. Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine*;Santini;Eur J Haematol,2010

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No advantage of antimicrobial prophylaxis in AML/MDS/CMML patients treated with azacitidine—a prospective multicenter study by the Polish Adult Leukemia Group;Frontiers in Oncology;2024-06-13

2. Real-World Outcome and Prognostic Factors in MDS Patients Treated with Azacitidine—A Retrospective Analysis;Cancers;2024-03-29

3. Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the Düsseldorf MDS Registry;Cancers;2024-02-16

4. Spectrum of infections in different regimens of post-induction chemotherapy in acute myeloid leukemia (de-novo): A comparative retrospective study;Heliyon;2024-02

5. Bloodstream gram-negative bacterial infections in adult patients with leukemia: A retrospective review of medical records in a tertiary care hospital in Western Saudi Arabia;Journal of Infection and Public Health;2023-10